Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
PubChem Thymalfasin record
Sequence, formula, mass and synonym record; CID 16130571.
RECONNECT bremelanotide phase 3 trials
Primary phase 3 publication; PMID 31599840.
DailyMed Vyleesi prescribing information
Current FDA-approved finished-drug label.
PubChem Bremelanotide record
Free-base peptide identity; CID 9941379.
Kisspeptin-10 response in men with type 2 diabetes
Small human pathway-response study; PMID 23153270.
PubChem Kisspeptin-10 record
Sequence, formula and mass; CID 25240297.
PubChem Kisspeptin-54 record
Longer peptide identity; CID 71306396.
2019 systematic review of glutathione skin outcomes
Earlier review documenting limited and inconsistent evidence; PMID 30895708.
PubChem reduced glutathione record
Sequence, formula and mass; CID 124886.
Semax protein-expression study in rat cerebral ischemia
Sequence and preclinical context; PMID 34201112.
FDA December 2024 PCAC meeting record
Regulatory meeting context.
ICH Q2(R2): Validation of Analytical Procedures
Official analytical-validation framework; not evidence that a specific catalog lot has been tested.
ICH Q14: Analytical Procedure Development
Official analytical-development framework; included as general method guidance only.
CJC-1295 albumin bioconjugation and receptor activity
CJC-1295 albumin bioconjugation and receptor activity
Survodutide phase 2 obesity trial
Dose-ranging clinical context; PMID 38330987.
FDA accelerated approval announcement for Forzinity
Approval scope and confirmatory requirement.
FDA Pharmacy Compounding Advisory Committee meeting materials
FDA assessment materials for ibutamoren and ipamorelin.
GHK-Cu wound research in a rat model
Preclinical context; PMID 8227353.
Review of mitochondrial-derived peptides in energy metabolism
Evidence-context review; PMID 32776825.
ICH Q1A(R2): Stability Testing of New Drug Substances and Products
Explains how temperature, humidity and light studies establish storage and retest or shelf-life claims.
ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
Section 11.4 lists batch-specific certificate-of-analysis fields and quality-unit approval expectations.
SURPASS-1 randomized phase 3 trial
Primary clinical trial record; PMID 34186022.
Tirzepatide receptor imbalance and signaling bias
Tirzepatide receptor imbalance and signaling bias
TRIUMPH-1 ClinicalTrials.gov record
Protocol and current study-status record.
Google guidance on people-first content and substantive date changes
Official Google Search Central guidance cited for the editorial-update statement.
Randomized trial of visceral and liver fat outcomes
Exploratory liver-fat evidence; PMID 25038357.
BPC-157 Achilles tendon study in rats and cultured tendocytes
Earlier component-specific preclinical context; PMID 14554208.
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
